Home/Filings/4/0001213900-23-040577
4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-23-040577

CIK 0001728328other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:58 PM ET

Size

5.4 KB

Accession

0001213900-23-040577

Insider Transaction Report

Form 4
Period: 2023-05-16
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2023-05-161,81826,139 total
    Exercise: $623.93From: 2018-05-16Exp: 2023-05-16Common shares (1,818 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817882

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:58 PM ET
Size
5.4 KB